Related Experiment Video

Updated: May 5, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.4K

Personalizing colon cancer therapeutics: targeting old and new mechanisms of action

Christina Leah B Kline1, Wafik S El-Deiry

  • 1Hematology/Oncology Division, Penn State Hershey Medical Center, Hershey, PA 17033, USA. Wafik.eldeiry@gmail.com.

Pharmaceuticals (Basel, Switzerland)
|November 27, 2013
PubMed

Insights

This review covers colon cancer chemotherapeutics, highlighting personalized medicine advances. It details predictive markers for drug efficacy and safety, and strategies for overcoming treatment resistance.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Colon cancer treatment is evolving towards personalized approaches.
  • New molecular tools are driving advancements in chemotherapy.
  • Understanding drug response and resistance is crucial for effective treatment.

Purpose of the Study:

  • To review established and novel colon cancer chemotherapeutics.
  • To identify parameters predicting chemotherapeutic efficacy and safety.
  • To explore alternative pharmaceutical strategies for non-responsive or resistant cases.

Main Methods:

  • Literature review of colon cancer chemotherapeutics.
  • Analysis of predictive biomarkers for drug response.
  • Examination of mechanisms of resistance and alternative treatments.

Main Results:

  • Personalized medicine is enhancing colon cancer treatment efficacy.
  • Specific molecular markers predict patient response to chemotherapy.
  • Development of alternative drugs addresses treatment resistance.

Conclusions:

  • Personalized chemotherapy, guided by predictive markers, improves colon cancer outcomes.
  • Understanding resistance mechanisms is key to developing next-generation therapies.
  • Continued research into molecular tools will further refine colon cancer treatment strategies.

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

6.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.8K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84